Cardiac Assessment Prior to Vascular Surgery: Is Dipyridamole-Sestamibi Necessary?
- 1 July 1996
- journal article
- research article
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 10 (4) , 325-329
- https://doi.org/10.1007/bf02286775
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Dipyridamole-Thallium Scintigraphy and Gated Radionuclide Angiography to Assess Cardiac Risk before Abdominal Aortic SurgeryNew England Journal of Medicine, 1994
- An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgeryJournal of Vascular Surgery, 1994
- The incidence of perioperative myocardial infarction in general vascular surgeryJournal of Vascular Surgery, 1992
- Accuracy and safety of technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (Sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: A multicenter studyJournal of the American College of Cardiology, 1991
- Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group.Circulation, 1991
- Combining Clinical and Thallium Data Optimizes Preoperative Assessment of Cardiac Risk before Major Vascular SurgeryAnnals of Internal Medicine, 1989
- Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981New England Journal of Medicine, 1988
- Dipyridamole-Thallium Scanning in Patients Undergoing Vascular SurgeryJAMA, 1987
- Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgeryJournal of Vascular Surgery, 1987
- Determination of Cardiac Risk by Dipyridamole-Thallium Imaging before Peripheral Vascular SurgeryNew England Journal of Medicine, 1985